- $27.52m
- $39.67m
- $37.06m
Brief: CytoSorbents And Converge Biotech Announce Strategic Partnership To Expand Sepsis And Critical Care Treatment With CytoSorb In India
Cytosorbents Corp reports results for the quarter ended in September 30 - Earnings Summary
Cytosorbents Corp expected to post a loss of 6 cents a share - Earnings Preview
Brief: Cytosorbents Submits Health Canada Medical Device License Application For Drugsorb-Atr After Mdsap Certification
Brief: Cytosorbents Corp Entered Agreement Which May Offer Up To $20 Million Common Stock Through Jefferies- SEC Filing
Brief: Cytosorbents Announces Inducement Grants Under Nasdaq Listing Rule
Brief: CytoSorbents Appoints Peter Mariani Chief Financial Officer
Cytosorbents Corp reports results for the quarter ended in June - Earnings Summary
Cytosorbents Corp expected to post a loss of 10 cents a share - Earnings Preview
Brief: CytoSorbents Announces Compliance With Nasdaq Minimum Bid Price Requirement
Cytosorbents Corp expected to post a loss of 9 cents a share - Earnings Preview
Brief: Cytosorbents Files For Mixed Shelf Offering Of Up To $150 Mln
Brief: Cytosorbents Secures $20 Mln Credit Facility
Brief: Cytosorbents Corp Regulatory Approval Of Cytosorb In Taiwan
Brief: CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union
Cytosorbents Corp reports results for the quarter ended in March - Earnings Summary
Cytosorbents Corp expected to post a loss of 12 cents a share - Earnings Preview
Brief: Cytosorbents Corp's Board Approves Voluntary Salary Reduction Program For Certain Of Employees
Cytosorbents Corp reports results for the quarter ended in December - Earnings Summary